ProQR Therapeutics (PRQR) Total Debt (2013 - 2025)

ProQR Therapeutics' Total Debt history runs 13 years deep, the most recent figure standing at $5.7 million for Q4 2025.

• In Q4 2025, Total Debt rose 15.83% year-over-year to $5.7 million; the TTM figure through Dec 2025 stood at $5.7 million (up 15.83% YoY), while the FY2025 annual figure was $5.7 million, up 15.83% from the prior year.
• Total Debt came in at $5.7 million for Q4 2025 at ProQR Therapeutics, up from $4.9 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $50.4 million in Q4 2021 to a low of $19910.1 in Q1 2021.
• A 5-year average of $15.2 million and a median of $5.3 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt sank 99.86% in 2021 and surged 216181.09% in 2022, its largest moves.
• ProQR Therapeutics' Total Debt stood at $50.4 million in 2021, then plunged by 86.3% to $6.9 million in 2022, then plunged by 33.15% to $4.6 million in 2023, then rose by 6.03% to $4.9 million in 2024, then gained by 15.83% to $5.7 million in 2025.
• According to Business Quant data, Total Debt over the past three periods registered $5.7 million, $4.9 million, and $4.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison